The antitumor effects of icaritin against breast cancer is related to estrogen receptors.

CONCLUSION: Our study demonstrated that the antitumor effects of icaritin against breast cancer are related with ER, which suggested that the status of ER should be considered in clinical application of icaritin.
PMID: 32472997 [PubMed - as supplied by publisher]

Source: Current Molecular Medicine - May 29, 2020 Category: Molecular Biology Authors: Tao CC, Wu Y, Gao X, Qiao L, Yang Y, Li F, Zou J, Wang YH, Zhang SY, Li CL, Zhang YY, Sun XD Tags: Curr Mol Med Source Type: research